Laboratorios Farmaceuticos (Spain) Today
| ROVI Stock | EUR 64.00 1.30 2.07% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Laboratorios Farmaceuticos is trading at 64.00 as of the 28th of November 2024, a 2.07 percent increase since the beginning of the trading day. The stock's open price was 62.7. Laboratorios Farmaceuticos has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Laboratorios Farmaceuticos ROVI are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. Laboratorios Farmaceticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L. The company has 51.32 M outstanding shares. More on Laboratorios Farmaceuticos ROVI
Moving together with Laboratorios Stock
Moving against Laboratorios Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Laboratorios Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Laboratorios Farmaceuticos' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Laboratorios Farmaceuticos or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Juan Encina |
| Business Concentration | Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) |
Laboratorios Farmaceuticos ROVI (ROVI) is traded on Madrid Exchange in Spain and employs 1,751 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.1 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Laboratorios Farmaceuticos's market, we take the total number of its shares issued and multiply it by Laboratorios Farmaceuticos's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Laboratorios Farmaceuticos operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 51.32 M outstanding shares.
Laboratorios Farmaceuticos ROVI has accumulated about 126.82 M in cash with 149.44 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.26.
Check Laboratorios Farmaceuticos Probability Of Bankruptcy
Ownership AllocationLaboratorios Farmaceuticos maintains a total of 51.32 Million outstanding shares. Laboratorios Farmaceuticos ROVI secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 60.25 % of Laboratorios Farmaceuticos ROVI outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Laboratorios Ownership Details
Laboratorios Farmaceuticos Risk Profiles
Although Laboratorios Farmaceuticos' alpha and beta are two of the key measurements used to evaluate Laboratorios Farmaceuticos' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.44 | |||
| Standard Deviation | 2.36 | |||
| Variance | 5.59 | |||
| Risk Adjusted Performance | (0.08) |
Laboratorios Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Laboratorios Farmaceuticos without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
| All Next | Launch Module |
Laboratorios Farmaceuticos Corporate Directors
| Fernando Morales | Commercial Director | Profile | |
| Miguel Freese | Independent Director | Profile | |
| Jose MorenoBarreda | Independent Director | Profile | |
| Miguel Sanchez | Industrial Director | Profile |
Other Information on Investing in Laboratorios Stock
Laboratorios Farmaceuticos financial ratios help investors to determine whether Laboratorios Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Laboratorios with respect to the benefits of owning Laboratorios Farmaceuticos security.